Fisher & Paykel Healthcare Corporation Limited is a New Zealand-based medical device company that specializes in the design, manufacture and marketing of products and systems for respiratory care and the treatment of obstructive sleep apnea. Headquartered in Auckland, the company focuses on delivering therapeutic solutions that enhance patient outcomes across a range of acute and chronic respiratory conditions.
The company’s product portfolio includes humidification systems used in mechanical ventilation, high-flow nasal cannula therapy devices for adult and neonatal care, continuous positive airway pressure (CPAP) machines and interfaces for sleep apnea treatment, as well as medical devices for non-invasive ventilation. These offerings are supported by proprietary technologies in flow, temperature and humidity control that aim to improve patient comfort and clinical efficacy.
Incorporated as a standalone entity in 2001, Fisher & Paykel Healthcare traces its roots to the Fisher & Paykel Appliances business, leveraging decades of engineering expertise and a long-standing commitment to research and development. Over time, the company has built a track record of clinical studies and product innovations that address evolving needs in respiratory therapy and neonatal care.
Fisher & Paykel Healthcare serves hospitals, clinics and homecare providers in more than 120 countries. It maintains manufacturing facilities, research centres and regional sales offices across Asia Pacific, North America and Europe, enabling close collaboration with healthcare professionals and rapid response to market requirements.
AI Generated. May Contain Errors.
Free FSPKF Stock Alerts